alexa Study Of Rare Disease Utilizing Bioinformatics Approach
ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd World Congress on Rare Diseases and Orphan Drugs
June 29-30, 2017 London, UK

Weida Tong
National Center for Toxicological Research - US FDA, USA
Posters & Accepted Abstracts: J Genet Syndr Gene Ther
DOI: 10.4172/2157-7412-C1-013
A rare disease, also referred to as an orphan disease, is any disease that affects a small percentage of the population. Among ~7000 rare diseases reported, only ~500 orphan drugs are available. The U.S. Food and Drug Administration (FDA) has implemented various policies to improve treatment options for rare diseases. As a result, in the last 10 years, over one-third of all new drug approvals by FDA were for rare diseases. There are a number of challenges to develop orphan drugs for rare diseases. For example, the lack of knowledge about the natural history of rare diseases is one important challenge for orphan drug development. Bioinformaticsbased approaches have the potential to offer systematic insights into the complex relationships among drugs, targets and rare diseases necessary for better understanding the natural history of rare disease and seeking for potential treatment options. We have employed diverse bioinformatics approaches with integrated data related to rare diseases to uncover the underlying mechanism of rare diseases and explore the potential application of the existing marketed drugs for the treatment of rare diseases. This presentation will describe several projects relating to the development of a bioinformatics framework for drug repositioning in rare diseases, deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for Cystic Fibrosis, and potential reuse of oncologic drugs for the treatment of rare diseases.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version